Author

Lauren Shumate

University of Massachusetts Chan Medical School

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Angela M. Matta· 1 shared Ann Marie MoormanniD· 1 shared Ann W. Kinyua· 1 shared Boaz OdwariD· 1 shared Catherine Suzanne ForconiiD· 1 shared Christian MünziD· 1 shared Cliff I. OduoriD· 1 shared Festus N'juguna· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Angela M. Matta

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphoma

Catherine Suzanne Forconi, Lauren Shumate, Zachary J. Racenet, Viriato M’Bana, Cliff I. Oduor, Angela M. Matta, Jeni Melo, Peter O. Oluoch, Boaz Odwar, Juliana A. Otieno, Terry A. Vik, Festus N'juguna, Ann W. Kinyua, Jeffrey A. Bailey, Christian Münz, Ann Marie Moormann

This study compares ADCC activity of CD56neg and CD56dim NK cells against EBV-type 1 and 2 Burkitt lymphoma cells, finding EBV-T2 cells are more susceptible to direct cytotoxicity.

bioRxiv · Feb 10, 2026 · PreprintImmunology